Reduction of the fluorine-18-labeled fluorodeoxyglucose dose for clinically dedicated breast positron emission tomography

PURPOSE: To determine the clinically acceptable level of reduction in the injected fluorine-18 ((18)F)-labeled fluorodeoxyglucose ((18)F-FDG) dose in dedicated breast positron emission tomography (dbPET). METHODS: A breast phantom with four spheres exhibiting various diameters (5, 7.5, 10, and 16 mm...

Descripción completa

Detalles Bibliográficos
Autores principales: Satoh, Yoko, Sekine, Tetsuro, Omiya, Yoshie, Onishi, Hiroshi, Motosugi, Utaroh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884607/
https://www.ncbi.nlm.nih.gov/pubmed/31784863
http://dx.doi.org/10.1186/s40658-019-0256-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884607/
https://www.ncbi.nlm.nih.gov/pubmed/31784863
http://dx.doi.org/10.1186/s40658-019-0256-9

Ejemplares similares